By assisting patients in achieving significant weight loss (10-20%) through the supplementation of Semaglutide injections in conjunction with dietary and lifestyle plan requirements, overweight and obese individuals can reduce not only their weight but the risk of developing chronic illnesses as well
Thanks to its antioxidant and anti-inflammatory properties, including its ability to regulate copper, the peptide is being explored as a potential treatment for conditions such as Alzheimers, Parkinsons, and cognitive decline related to aging (8)
Most patients reporting subjective benefit notice energy improvement within 48-72 hours of the first injection, with peak effect at days 4-7
Dhahan N
Patients and methods: A systematic review and meta-analysis of randomized-controlled clinical trials (RCTs) was performed to estimate: (i) the incidence of major adverse cardiovascular events (MACE)
Semaglutide acts like GLP-1, which assists in boosting insulin release, stopping glucagon secretion and delaying stomach emptying